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Background: Asymptomatic Plasmodium parasite infections
occur frequently in people where malaria is endemic, and, if game-
tocytemic, represent a source of “silent” transmission that is not
associatedwithmalaria disease.Microscopy is insufﬁcient todetect
mostgametocyte infections,whichoccurat lowdensities relative to
asexual parasite stages. A novel, highly sensitive and speciﬁc quan-
titative reverse transcription polymerase chain reaction (qRT-PCR)
assay was recently created that uses ﬁve markers to distinguish
developing and mature P. falciparum gametocytes from asexual
stages at submicroscopic densities.
Methods & Materials: We evaluated this assay using human
blood samples collected during October 2012 in a cross-sectional,
all-ages, household-level study of the International Center of Excel-
lence forMalaria Research (ICEMR) project inMalawi.We aimed to
deﬁne potential infectious reservoirs by assessing prevalence and
predictors of submicroscopic gametocyte infection in three sett-
ings representing urban/low (Blantyre), semi-rural/mountainous
(Thyolo), and rural/high (Chikhwawa) transmission. Of 2,795 peo-
ple who were surveyed and sampled for Plasmodium microscopy,
additional blood from a subset of 628 people was collected into
RNAprotect for qRT-PCR testing. Samples that tested positive for P.
falciparum lactate dehydrogenasegDNA by PCR were further tested
using the qRT-PCR assay to assess relative stage distribution.
Results: While microscopy detected only one sample with
gametocytes, qRT-PCR identiﬁed 31 gametocytemic samples,
including 7 with only developing gametocytes, 7 with mature
gametocytes, and 17 with both developing and mature gameto-
cytes. We present data on the predictors of gametocytemia and
compare these results with microscopic and molecular results for
asexual parasites. Age categorywas strongly associatedwith game-
tocytemia (p<0.0001), with 2.1% of children under 5 years, 9.1% of
children 5 to 15 years, and 1.1% of adults carrying mature gameto-
cytes in this dry season sample.
Conclusion: The use of a new molecular assay enabled us to
identify a large number of submicroscopic gametocyte infections,
most of which were asymptomatic in this cross-sectional sample.
School-aged children represent an important potentially infectious
reservoir that may require a targeted control approach. A better
understanding of which humans may be unrecognized sources of
parasite transmission is critical in order to enhance malaria inter-
ventions, particularly in areas approaching elimination.
http://dx.doi.org/10.1016/j.ijid.2014.03.942
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Background: Studies investigating the prevalence of Salmonella
carriers are lacking, especially from African countries, and to
date, little research has been dedicated to investigating the role
of chronic carriers in Salmonella infection and transmission in
endemic regions.
Methods & Materials: This study utilizes stool culture diagnos-
tics to identify the prevalence of Salmonella Typhi, non-typhoidal
Salmonella (NTS), and Salmonella ParaTyphi carrierswithin the gen-
eral populations in two sites, located in Guinea-Bissau and Senegal,
respectively. Conducted along side the Typhoid Fever Surveil-
lance in Africa Program (TSAP), CISAS will additionally identify
potential carriers within households of conﬁrmed acute Salmonella
cases. Study participants of all ages and both sexes from randomly
selected households within the TSAP catchment areas are consid-
ered for inclusion. Bacterial pathogens are isolated from positive
stool culture and conﬁrmed using biochemical and agglutination
reactions. Thirty-day follow-up of patients with positive stool
culture will help track periodicity of bacterial shedding, and sub-
sequent monthly follow-up will bear light on clearance patterns.
Antibiotic resistance is assessed and genetic analyses of isolated
Salmonellae will be carried out to investigate phylogenetic related-
ness of strains and to understand possible transmission pathways.
Results: A total of 1,313 stool cultures from participants in 164
households have been processed in Guinea-Bissau with 27 (2.6%)
cultures positive for Salmonella spp. from individuals ranging from
5 to 40 years. A total of 555 stool cultures from participants in 90
households have been investigated in Senegal with 7 (1.3%) posi-
tive for salmonellae from individuals ranging from 3 to 55 years.
All identiﬁed isolates from both sites have been conﬁrmed as NTS
and 6 patients from Guinea Bissau have shown repeat positive cul-
tures from within 30 days of identiﬁcation. Resistance was found
against chloramphenicol (1/22), nalidixic acid (1/21), and trimetho-
prim/sulfamethoxazole (1/23) in Guinea Bissau, and in Senegal,
isolates showed resistance to ciproﬂoxacin (1/7) and nalidixic acid
(2/7).
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Conclusion: Identiﬁcation of a population of carriers of
Salmonella spp. in an endemic region would provide evidence for
a targeted means of transmission containment and prevention,
including sensibilization and sanitation enforcement followed by
potential vaccination of at-risk populations.
http://dx.doi.org/10.1016/j.ijid.2014.03.943
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Background:Hypothesis:Massdrugadministration (MDA)will
be an effective public health measure to reduce the prevalence of
scabies and strongyloidiasis in a remote Aboriginal community in
Australia where both parasitic infections are endemic.
Methods & Materials: A population census and MDA was
conducted in 2010 and 2011 to screen participants for scabies
and strongyloidiasis and administer medications. Scabies was
diagnosed clinically, strongyloidiasis serologically or from copro-
ligcal examination. Participants were administered a stat dose of
200g/kg ivermectin unless their weight was <15kg or pregnant.
Participants diagnosed with scabies and/or strongyloidiasis were
given a 2nd treatment 2-3 weeks after the ﬁrst medications were
administered.
Two cross sectional surveys were conducted 6 months after
the MDA to follow-up participants who had been diagnosed with
scabies and/or strongyloidiasis to determine treatment failures.
Disease acquisition was measured from a sample of participants
who had no scabies or strongyloidiasis at the population census 6
months prior.
Results: At the population census and MDA in 2010, 1012 (80%)
participants were screened from 127 (80%) houses in the remote
community and 7 surrounding homelands. Scabies prevalence was
4% and strongyloidiasis was 21%. In 2011, 1060 participants were
screened, 702 that had been seen previously and 358 new entries.
The prevalence of scabies increased to 9% for participants seen pre-
viously with strongyloidiasis prevalence decreasing to 6%.
At the cross sectional surveys, 80% of participantswere followed
up. The treatment failures remained constant at 6% (2010) and
7% (2011) for scabies increasing slightly but not signiﬁcantly from
17% (2010) to 23% (2011) for strongyloidiasis. Scabies acquisition
increased but not signiﬁcantly from 3% (2010) to 8% (2011) and
decreased from 4% (2010) to 1% (2011) for strongyloidiasis. Scabies
prevalence decreased signiﬁcantly at both cross sectional surveys
from 4% to 1% in 2010 and 9% to 2% in 2011. Strongyloidiasis preva-
lence decreased signiﬁcantly from 21% to 6% which was sustained
for the duration of the project.
Conclusion: Scabies and strongyloidiasis are neglected tropical
diseases that contribute to the signiﬁcantmorbidity experiencedby
Australian Aboriginals in remote communities. MDA is an effective
public health measure to reduce the prevalence of both parasitic
infections.
http://dx.doi.org/10.1016/j.ijid.2014.03.944
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Measles-mumps-rubeola (MMR), varicella, and
hepatitis A (HAV) seroprevalances among
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Background: In this study, we aimed to determine theMeasles-
Mumps- Rubeola (MMR), Varicella, and Hepatitis A (HAV) sero-
prevalences among the healthcare workers (HCWs) and also their
compliance to vaccination.
Methods & Materials: The health records of 5040 HCWs, who
admitted to the Vaccination Clinic for HCWs, were evaluated retro-
spectively. Seropositivity rates to MMR, Varicella, and HAV were
calculated, HCWs’ compliance to the vaccinations were investi-
gated. Statistical package SPSS version 15 was used to conduct
analysis.
Results: The HAV, MMR and Varicella seropositivity rates,
among the HCWs, were 70, 6%, 81, 5%, 83, 8%, 94, 7% and 95, 2%,
respectively. Anti-HAV positivity was found higher in nurses and
doctors than the nursing andmedical students (p <0,001). Seropos-
itivity rate to measles was found lower in students, young and
female personnel (p <0, 01). No association was found between a
history of infection and the seropositivity (Table 1). Compliance
rates to vaccination were found between 33, 5% and 63, 3%. Com-
pliance was higher in females, younger than 20 years, and students
(p <0,001).
Conclusion: In the past, HAV seropositivity rates among HCWs
were reported higher than the community (90, 4%-99, 5% vs. 40%-
80, 8%) in Turkey. In our study, HAV seropositivity (70, 6%) was not
founddifferent fromthecommunity’s rates. This couldbeexplained
with the improvement in the condition of hygiene in the commu-
Table 1
HCWs’ history of illness and seropositivity due to the infection.
Infection (Total Number) Seropositivity (%) History of illness (%)*
Yes No
Rubella (2451) 2321 (94,7) 100 97,7
Measles (1558) 1269 (81,5) 93,3 92,6
Mumps (1010) 846 (83,8) 90,7 69,2
Varicella (852) 811 (95,2) 100 95,2
*Seropositivity rates due to the history of illness.
